SCHEMBL7416884

SCHEMBL7416884

CC(C)(O)C(C)(C)OB(O)CCSc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.41
MAPK1 P28482 1/20 0.41
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
NPC1 O15118 6/20 0.36
RAB9A P51151 6/20 0.36
SMN1; SMN2 Q16637 5/20 0.36
RECQL P46063 1/20 0.36
FDPS P14324 3/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
HPGD P15428 3/20 0.35
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC2 Q92769 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5838358 0.84 ALDH1A1 (0.35) ALDH1A1MAPK1MTNR1AMTNR1BNPC1
SCHEMBL670441 0.72 LIPE (0.35) ALDH1A1FDPSLMNACYP1A2CYP2C19
SCHEMBL15229065 0.68 MAOA (0.35) ALDH1A1CYP2D6MEN1KMT2AMAPT
SCHEMBL7179298 0.68 L3MBTL1 (0.33) MAPK1SMN1; SMN2LMNAMAPT
SCHEMBL19514665 0.68 MEN1 (0.40) ALDH1A1HPGDLMNAHDAC1HDAC6
SCHEMBL9125570 0.68 CA2 (0.57) ALDH1A1MAPK1MTNR1AMTNR1BNPC1
SCHEMBL17652426 0.67 IDO1 (0.38) ALDH1A1SMN1; SMN2RECQLHPGDUSP2
SCHEMBL119711 0.66 TRPV6 (0.39) ALDH1A1MAPK1CYP2C19
SCHEMBL18550022 0.65 AOC3 (0.38) ALDH1A1SMN1; SMN2FDPSNFKB1LMNA
SCHEMBL5953079 0.64 ANPEP (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1206449-A1 LACTAM INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE BRISTOL-MYERS SQUIBB COMPANY (US) 2002-05-22 EP disclosed
WO-2001007407-A1 LACTAM INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-02-01 WO disclosed